Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Dujovne

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Expert Opinion on Investigational Drugs|September 13, 2002
Anti-obesity drug developmentHarold Bays, Carlos Dujovne
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Pharmacotherapy of obesity: currently marketed and upcoming agentsHarold Bays, Carlos Dujovne
Expert Opinion on Pharmacotherapy|May 13, 2003
Colesevelam HCl: a non-systemic lipid-altering drugHarold Bays, Carlos Dujovne
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|September 13, 2002
Anti-obesity drug developmentHarold Bays, Carlos Dujovne
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Pharmacotherapy of obesity: currently marketed and upcoming agentsHarold Bays, Carlos Dujovne
Expert Opinion on Pharmacotherapy|May 13, 2003
Colesevelam HCl: a non-systemic lipid-altering drugHarold Bays, Carlos Dujovne
Pageof 1